Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?

被引：6
|
作者：
Hadda, Vijay [1 ]
Guleria, Randeep [1 ]
机构：
[1] All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2020年 / 152卷 / 03期
关键词：
PIRFENIDONE; NINTEDANIB; EFFICACY; UPDATE; TRIAL;
D O I：
10.4103/ijmr.IJMR_90_20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：177 / 180
页数：4
相关论文
共 50 条
  • [1] What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis
    Puglisi, S.
    Torrisi, S. E.
    Giuliano, R.
    Vindigni, V.
    Vancheri, C.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (03) : 358 - 367
  • [2] Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis?
    Cottin, Vincent
    Cordier, Jean-Francois
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (01) : 250 - 251
  • [3] Antifibrotic choice in idiopathic pulmonary fibrosis
    Hayton, Conal
    Morris, Helen
    Marshall, Tracey
    Zakis, Katie
    Garfoot, Theresa
    Ortega, Pilar Rivera
    Greaves, Melanie
    Leonard, Colm
    Chaudhuri, Nazia
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [4] Antifibrotic treatment of idiopathic pulmonary fibrosis
    Markart, P.
    Drakopanagiotakis, F.
    Wygrecka, M.
    [J]. PNEUMOLOGE, 2020, 17 (03): : 177 - 185
  • [5] Antifibrotic therapy for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
    Teoh, A.
    Glenn, L.
    Corte, T.
    Holland, A.
    [J]. RESPIROLOGY, 2023, 28 : 202 - 202
  • [6] Interferon-γ 1b in idiopathic pulmonary fibrosis -: What we know and what must we learn
    Dauber, JH
    Gibson, KF
    Kaminski, N
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (02) : 107 - 108
  • [7] We Should Prohibit Warfarin in Idiopathic Pulmonary Fibrosis
    Alagha, Khuder
    Secq, Veronique
    Pahus, Laurie
    Sofalvi, Tunde
    Palot, Alain
    Bourdin, Arnaud
    Chanez, Pascal
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191 (08) : 958 - 960
  • [8] Desensitization to Pirfenidone in a Patient Diagnosed With Idiopathic Pulmonary Fibrosis and Hypersensitivity to Antifibrotic Drugs
    Leon-Roman, Francisco
    Alonso-Gomez, Alicia
    Carron-Herrero, Alejandra
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (10): : 710 - +
  • [9] Safety of antifibrotic drugs in idiopathic pulmonary fibrosis patients awaiting lung transplantation
    Chirinos Guevara, Roxana Genoveva
    Velez, Eduardo
    Berastegui, Cristina
    Villar, Ana
    Revilla, Eva
    Sintes, Helena
    Saez, Berta
    Lopez Meseguer, Manuel
    Bravo, Carles
    Monforte, Victor
    Roman, Antonio
    Bello, Irene
    Sacanell, Judit
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [10] Revealing Real-Life Experiences With Antifibrotic Drugs in Idiopathic Pulmonary Fibrosis
    Buendia-Roldan, Ivette
    Mejia, Mayra
    Selman, Moises
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (02): : 73 - 74
12345